0001193125-12-000482.txt : 20120103 0001193125-12-000482.hdr.sgml : 20120102 20120103125433 ACCESSION NUMBER: 0001193125-12-000482 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120103 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120103 DATE AS OF CHANGE: 20120103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LINCARE HOLDINGS INC CENTRAL INDEX KEY: 0000882235 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510331330 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19946 FILM NUMBER: 12500995 BUSINESS ADDRESS: STREET 1: 19387 US 19 NORTH CITY: CLEARWATER STATE: FL ZIP: 33764 BUSINESS PHONE: 8135307700 MAIL ADDRESS: STREET 1: 19387 US 19 NORTH CITY: CLEARWATER STATE: FL ZIP: 33764 8-K 1 d276662d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 3, 2012

 

 

Lincare Holdings Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-19946   51-0331330

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification Number)

19387 U.S. 19 North, Clearwater, FL 33764

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: 727-530-7700

 

(Former name or address, if changed from last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events

On January 3, 2012, the Company announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per common share. The dividend is payable on January 31, 2012 to stockholders of record as of the close of business on January 17, 2012.

 

Item 9.01 Financial Statements and Exhibits

 

  (d) Exhibits

 

  99.1 Press Release of Lincare Holdings Inc., dated January 3, 2012

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Lincare Holdings Inc.
By:  

/s/ Paul G. Gabos

  Paul G. Gabos
  Chief Financial Officer, Treasurer and Secretary

January 3, 2012

EXHIBIT INDEX

 

Exhibit
Number

   

Description

99.1    Press Release of Lincare Holdings Inc., dated January 3, 2012
 EX-99.1 2 d276662dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

Lincare Holdings Inc. Declares Quarterly Cash Dividend

Press Release Source: Lincare Holdings Inc. On Tuesday, January 3, 2012, 9:00 am EDT

CLEARWATER, Fla., Jan. 3, 2012 (GLOBE NEWSWIRE) — Lincare Holdings Inc. (Nasdaq:LNCR - News) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per common share. The dividend is payable on January 31, 2012 to stockholders of record as of the close of business on January 17, 2012.

Lincare, headquartered in Clearwater, Florida, is one of the nation’s largest providers of respiratory therapy and other services to patients in the home. The Company provides services and equipment to more than 800,000 customers in 48 U.S. states and Canada.

Statements in this release concerning future results, performance or expectations are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All forward-looking statements included in this document are based upon information available to Lincare as of the date hereof and Lincare assumes no obligation to update any such forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause Lincare’s actual results, levels of activity, performance or achievements, or ability to pay a cash dividend to be materially different from any results, levels of activity, performance or achievements, or plans to pay a cash dividend expressed or implied by any forward-looking statements. In some cases, forward-looking statements that involve risks and uncertainties contain terminology such as “may,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or variations of these terms or other comparable terminology.

Future payment of cash dividends or any changes in the dividend amount will depend on the judgment of our Board of Directors based upon the best interests of the Company, its shareholders and other factors. Such factors may include the Company’s earnings prospects, capital requirements, financial condition, financing restrictions, regulatory requirements and other factors deemed relevant by our Board of Directors. Our Board of Directors will review the dividend annually or at more frequent intervals as determined by our Board.

Contact:

Paul G. Gabos

(727) 530-7700